April 5, 2025 (Houston, TX) – ROSEAId, Inc. have entered into a strategic collaboration with Mikroscan Technologies, a leader in advanced microscopy solutions, to develop an AI-powered microscopy system that pushes the boundaries of scientific research and clinical operations in cancer identification.
The collaboration will leverage Mikroscan’s L5 and SL5 advanced microscopy and digital pathology hardware with ROSEAId’s sophisticated AI approach, resulting in an integrated system that enhances imaging capabilities and provides researchers with an exceptional ability to detect and classify cancer at an early stage. The initial indication will focus on colorectal cancer screening and early-stage detection. Over time, the platform will be adapted for use across various cancer types, broadening its clinical application.
"We are confident that our collaboration with Mikroscan will transform early cancer detection, leveraging AI for improved efficiency and seamless workflows with a focus on underserved rural communities,” said Joseph A. Rossi, CEO of ROSEAId.
These communities will benefit in particular from the ability to use the integrated system remotely, offering real-time analysis from distant locations and enabling healthcare professionals to make faster, more informed decisions.
"This partnership is a significant step forward in AI-driven microscopy, setting new standards in cancer research and diagnostics," said Martin Stuart, president and CEO of Mikroscan.
Both companies will work to develop a comprehensive Go-to-Market (GTM) strategy initially targeting the US market with further plans for global expansion.
For more information, please visit ROSEAId.
About ROSEAId
ROSEAId, Inc - is a health sciences AI company with advanced technology in telepathology supporting clinical operations and research, leveraging AI-driven and machine learning models to identify regions of interest for early cancer detection. ROSEAId empowers healthcare professionals with solutions to make informed decisions while streamlining clinical workflows. It continues to drive innovation in early cancer detection, research and personalized outcomes, delivering faster, more accurate solutions to pressing challenges in cancer.
About Mikroscan
Mikroscan Technologies, Inc - specializes in digital pathology and telemicroscopy solutions providing high-quality, accessible diagnostic tools worldwide. Their high-performance imaging systems and medical applications have been at the forefront of advancing scientific research, supporting industries in fields such as biotechnology, healthcare and education and that has made them a trusted partner globally.
For media inquiries contact: Media Relations
Media@roseaid.com
